Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Extracorporeal Membrane Oxygenators (ECMO) Market by Type (Infant Paediatric Oxygenators, Adult Oxygenators), By Application (Respiratory, Cardiac, Extra-Corporeal Cardiopulmonary Resuscitation (ECPR), Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Extracorporeal Membrane Oxygenators (ECMO) Market by Type (Infant Paediatric Oxygenators, Adult Oxygenators), By Application (Respiratory, Cardiac, Extra-Corporeal Cardiopulmonary Resuscitation (ECPR), Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 170126 3300 Medical Devices & Consumables 377 239 Pages 4.6 (43)
                                          

Extracorporeal membrane oxygenators (ECMO) are devices that provide oxygen to the body when the lungs and heart are unable to do so. ECMOs can be used in a variety of situations, including respiratory failure, cardiac arrest, and as a bridge to lung transplantation. The global ECMO market is expected to grow at a CAGR of 5.5% from 2021-2030. The global ECMO market is segmented by type into infant paediatric oxygenators and adult oxygenators; by application into respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR); and by region into North America, Latin America, Europe, Asia Pacific & Middle East & Africa. North America is expected to account for the largest share of the global ECMO market during the forecast period owing to its high prevalence of chronic obstructive pulmonary disease (COPD), which leads to respiratory failure in many patients.

Some Of The Growth Factors Of This Market:

  1. The growth of the ECMO market is driven by factors such as increasing incidence of respiratory failure, increasing number of patients with chronic lung disease, and rising prevalence of heart failure.
  2. Increasing awareness about the benefits offered by ECMO devices will also drive the growth in this market.
  3. Factors such as high cost and lack of trained professionals are restraining the growth in this market.
  4. The global ECMO device market is segmented on the basis of type, end user, and geography.

Industry Growth Insights published a new data on “Extracorporeal Membrane Oxygenators (ECMO) Market”. The research report is titled “Extracorporeal Membrane Oxygenators (ECMO) Market research by Types (Infant Paediatric Oxygenators, Adult Oxygenators), By Applications (Respiratory, Cardiac, Extra-Corporeal Cardiopulmonary Resuscitation (ECPR), Others), By Players/Companies Getinge, Medtronic, LivaNova, Chalice Medical, MicroPort, NIPRO, XENIOS, OriGen Biomedical, EUROSETS S.r.l., Braile Biomédica, WEGO, Xijian Medical”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Extracorporeal Membrane Oxygenators (ECMO) Market Research Report

By Type

Infant Paediatric Oxygenators, Adult Oxygenators

By Application

Respiratory, Cardiac, Extra-Corporeal Cardiopulmonary Resuscitation (ECPR), Others

By Companies

Getinge, Medtronic, LivaNova, Chalice Medical, MicroPort, NIPRO, XENIOS, OriGen Biomedical, EUROSETS S.r.l., Braile Biomédica, WEGO, Xijian Medical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

239

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Extracorporeal Membrane Oxygenators (ECMO) Industry Outlook


Global Extracorporeal Membrane Oxygenators (ECMO) Market Report Segments:

The global Extracorporeal Membrane Oxygenators (ECMO) market is segmented on the basis of:

Types

Infant Paediatric Oxygenators, Adult Oxygenators

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Respiratory, Cardiac, Extra-Corporeal Cardiopulmonary Resuscitation (ECPR), Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Getinge
  2. Medtronic
  3. LivaNova
  4. Chalice Medical
  5. MicroPort
  6. NIPRO
  7. XENIOS
  8. OriGen Biomedical
  9. EUROSETS S.r.l.
  10. Braile Biomédica
  11. WEGO
  12. Xijian Medical

Global Extracorporeal Membrane Oxygenators (ECMO) Market Overview


Highlights of The Extracorporeal Membrane Oxygenators (ECMO) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Infant Paediatric Oxygenators
    2. Adult Oxygenators
  1. By Application:

    1. Respiratory
    2. Cardiac
    3. Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Extracorporeal Membrane Oxygenators (ECMO) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Extracorporeal Membrane Oxygenators (ECMO) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Extracorporeal membrane oxygenators (ECMO) are a type of mechanical ventilation that uses an external device to provide supplemental oxygen to the lungs. ECMO is used when the patient cannot breathe on their own or when they have severe respiratory failure.

Some of the major companies in the extracorporeal membrane oxygenators (ecmo) market are Getinge, Medtronic, LivaNova, Chalice Medical, MicroPort, NIPRO, XENIOS, OriGen Biomedical, EUROSETS S.r.l., Braile BiomƒÂ©dica, WEGO, Xijian Medical.

The extracorporeal membrane oxygenators (ecmo) market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Extracorporeal Membrane Oxygenators (ECMO) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Extracorporeal Membrane Oxygenators (ECMO) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Extracorporeal Membrane Oxygenators (ECMO) Market - Supply Chain
   4.5. Global Extracorporeal Membrane Oxygenators (ECMO) Market Forecast
      4.5.1. Extracorporeal Membrane Oxygenators (ECMO) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Extracorporeal Membrane Oxygenators (ECMO) Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Extracorporeal Membrane Oxygenators (ECMO) Market Absolute $ Opportunity

5. Global Extracorporeal Membrane Oxygenators (ECMO) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Type
      5.3.1. Infant Paediatric Oxygenators
      5.3.2. Adult Oxygenators
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Extracorporeal Membrane Oxygenators (ECMO) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Application
      6.3.1. Respiratory
      6.3.2. Cardiac
      6.3.3. Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
      6.3.4. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Extracorporeal Membrane Oxygenators (ECMO) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Extracorporeal Membrane Oxygenators (ECMO) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Extracorporeal Membrane Oxygenators (ECMO) Demand Share Forecast, 2019-2026

9. North America Extracorporeal Membrane Oxygenators (ECMO) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Application
      9.4.1. Respiratory
      9.4.2. Cardiac
      9.4.3. Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
      9.4.4. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Type
      9.7.1. Infant Paediatric Oxygenators
      9.7.2. Adult Oxygenators
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Extracorporeal Membrane Oxygenators (ECMO) Demand Share Forecast, 2019-2026

10. Latin America Extracorporeal Membrane Oxygenators (ECMO) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Application
      10.4.1. Respiratory
      10.4.2. Cardiac
      10.4.3. Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
      10.4.4. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Type
      10.7.1. Infant Paediatric Oxygenators
      10.7.2. Adult Oxygenators
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Extracorporeal Membrane Oxygenators (ECMO) Demand Share Forecast, 2019-2026

11. Europe Extracorporeal Membrane Oxygenators (ECMO) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Application
      11.4.1. Respiratory
      11.4.2. Cardiac
      11.4.3. Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
      11.4.4. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Extraorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Type
      11.7.1. Infant Paediatric Oxygenators
      11.7.2. Adult Oxygenators
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Extracorporeal Membrane Oxygenators (ECMO) Demand Share, 2019-2026

12. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Application
      12.4.1. Respiratory
      12.4.2. Cardiac
      12.4.3. Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
      12.4.4. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Type
      12.7.1. Infant Paediatric Oxygenators
      12.7.2. Adult Oxygenators
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Extracorporeal Membrane Oxygenators (ECMO) Demand Share, 2019-2026

13. Middle East & Africa Extracorporeal Membrane Oxygenators (ECMO) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Application
      13.4.1. Respiratory
      13.4.2. Cardiac
      13.4.3. Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
      13.4.4. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Extracorporeal Membrane Oxygenators (ECMO) Market Size and Volume Forecast by Type
      13.7.1. Infant Paediatric Oxygenators
      13.7.2. Adult Oxygenators
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Extracorporeal Membrane Oxygenators (ECMO) Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Extracorporeal Membrane Oxygenators (ECMO) Market: Market Share Analysis
   14.2. Extracorporeal Membrane Oxygenators (ECMO) Distributors and Customers
   14.3. Extracorporeal Membrane Oxygenators (ECMO) Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Getinge
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Medtronic
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. LivaNova
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Chalice Medical
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. MicroPort
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. NIPRO
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. XENIOS
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. OriGen Biomedical
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. EUROSETS S.r.l.
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Braile Biomédica
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. WEGO
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Xijian Medical
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us